Nature Biotechnology 2005 Mark Ratner - Abstracts
| Nature Biotechnology 2005 Mark Ratner | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Earlier stage biotechs attract partners. | Business | Mark Ratner | |||
| Jean Deleage. | Business | Mark Ratner | |||
| Maturing biotechs turn to pharma's markets. | Business | Mark Ratner | |||
| New IGF drug stirs competition in growth factor segment . | Business | Mark Ratner | |||
| Syrrx acquisition signals maturation of structure-based discovery.(Takeda Chemical Industries Ltd. acquires Syrrx) | Business | Mark Ratner | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.